# Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

> **NCT00806650** · — · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 155 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **GENETIC:** gene expression analysis
- **GENETIC:** protein expression analysis
- **DIAGNOSTIC_TEST:** diagnostic laboratory biomarker analysis
- **OTHER:** immunoenzyme technique
- **OTHER:** immunohistochemistry staining method

## Key facts

- **NCT ID:** NCT00806650
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2017-11-15
- **Final completion:** 2017-11-15
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2017-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806650, "Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00806650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*